Chapter 1. Nuclear Medicine Diagnostics Market- Scope & Methodology
1.1    Market Segmentation
1.2    Assumptions
1.3    Research Methodology
1.4    Primary Sources
1.5    Secondary Sources
Chapter 2. Nuclear Medicine Diagnostics Market- Executive Summary
2.1    Market Size & Forecast – (2023 – 2030) ($M/$Bn)
2.2    Key Trends & Insights
2.3    COVID-19 Impact Analysis
         2.3.1    Impact during 2023 – 2030
        2.3.2    Impact on Supply – Demand
Chapter 3. Nuclear Medicine Diagnostics Market- Competition Scenario
3.1    Market Share Analysis
3.2    Product Benchmarking
3.3    Competitive Strategy & Development Scenario
3.4    Competitive Pricing Analysis
3.5    Supplier - Distributor Analysis
Chapter 4. Nuclear Medicine Diagnostics Market- Entry Scenario
4.1     Case Studies – Start-up/Thriving Companies
4.2     Regulatory Scenario - By Region
4.3    Customer Analysis
4.4     Porter's Five Force Model
        4.4.1     Bargaining Power of Suppliers
        4.4.2     Bargaining Powers of Customers
        4.4.3    Threat of New Entrants
        4.4.4    .Rivalry among Existing Players
        4.4.5    Threat of Substitutes
Chapter 5. Nuclear Medicine Diagnostics Market- Landscape
5.1     Value Chain Analysis – Key Stakeholders Impact Analysis
5.2    Market Drivers
5.3    Market Restraints/Challenges
5.4    Market Opportunities 
Chapter 6. Nuclear Medicine Diagnostics Market- By Type
6.1    PET radiopharmaceuticals
6.2    SPECT radiopharmaceuticals
Chapter 7. Nuclear Medicine Diagnostics Market- By Modality
7.1    SPECT
7.2    PET
7.3    Alpha-emitters
7.4    Beta-emitters
7.5    Brachytherapy
Chapter 8. Nuclear Medicine Diagnostics Market- By Application
8.1    Cardiology
8.2    Thyroid
8.3    Neurology
8.4    Oncology
8.5    Others
Chapter 9. Nuclear Medicine Diagnostics Market- By Procedure
9.1    Oncology
9.2    Cardiovascular
9.3    Central Nervous System
9.4    Endocrine
9.5    Skeletal
9.6    Gastrointestinal
9.7    Genito-urinary
9.8    Pulmonary
9.9    PET & PET-CT
9.10    Therapeutic
9.11    Others
 Chapter 10. Nuclear Medicine Diagnostics Market- By End User
10.1    Hospitals and diagnostic centers
10.2    Research Institutes
Chapter 11. Nuclear Medicine Diagnostics Market- By Region
11.1    North America
11.2    Europe
11.3    Asia-Pacific
11.4    Latin America
11.5    The Middle East
11.6    Africa
Chapter 12. Nuclear Medicine Diagnostics Market- Company Profiles – (Overview, Product Portfolio, Financials, Developments)
12.1    Company 1
12.2    Company 2
12.3    Company 3
12.4    Company 4
12.5    Company 5
12.6    Company 6
12.7    Company 7
12.8    Company 8
12.9    Company 9
12.10    Company 10
 

Download Sample